Intraosseous Infusion Devices Market Size & Growth Forecast 2027–2036, By Segments (Type, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Intraosseous Infusion Devices Market size was valued at USD 1.1 billion in 2026 and is projected to grow at a 5.89% CAGR from 2027 to 2036, surpassing USD 1.95 billion by 2036. The industry revenue for 2027 is estimated at USD 1.15 billion.
Get more details on this report
Request Free Sample ReportIntraosseous Infusion Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America captured 43.78% of the market in 2026, supported by established emergency care infrastructure, routine intraosseous access use, and well-equipped hospital and ambulance networks.
- Asia Pacific is forecast to grow at a 7.12% CAGR as emergency care capacity expands, trauma services improve, and healthcare systems increasingly adopt advanced critical care protocols and rapid vascular access devices.
Segment Momentum
- Manual IO Needles accounted for 52.36% of the market in 2026, supported by broad clinical familiarity, simple deployment, dependable performance without power requirements, and seamless integration into emergency care protocols.
- Ambulatory Surgical Centers are expanding rapidly as they strengthen emergency preparedness and adopt intraosseous access devices that support rapid intervention, workflow continuity, and efficient response to unexpected procedural complications.
Market Expansion Drivers
- Rising emergency care cases and trauma incidence increasing demand for rapid vascular access solutions.
- Growing geriatric population and cardiovascular disease burden driving emergency intervention needs.
- Advancements in emergency medical device technology improving intraosseous access safety and efficiency.
Leading Market Participants
- Top players in the intraosseous infusion devices market include Teleflex Incorporated (United States), Becton, Dickinson and Company (United States), Cook Medical LLC (United States), SAM Medical Products (United States), Cardinal Health, Inc. (United States), Argon Medical Devices, Inc. (United States), Aero Healthcare Pty Ltd. (Australia), BIOPSYBELL S.R.L. (Italy), Pyng Medical Corporation (Canada), PerSys Medical, Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.1 billion
- 2027 Estimated Market Size: USD 1.15 billion.
- Projected Market Size: USD 1.95 billion by 2036
- Growth Forecast: 5.89% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Manual IO Needles (Type) | Hospitals and Clinics (End-use)
- Emerging Opportunity Segment: Battery Powered Driver (Type) | Ambulatory Surgical Centers (End-use)
Market Growth Drivers and Industry Trends
Rising emergency care cases and trauma incidence increasing demand for rapid vascular access solutions
The intraosseous infusion devices market is gaining relevance as emergency care and trauma cases require rapid access when conventional intravenous access is difficult or delayed. Intraosseous systems provide an alternative route for delivering fluids and medications during urgent interventions, supporting faster emergency response and treatment initiation.
Growing geriatric population and cardiovascular disease burden driving emergency intervention needs
A growing geriatric population and increasing cardiovascular disease burden are contributing to greater emergency intervention requirements, creating additional demand in the intraosseous infusion devices market. Patients requiring urgent treatment may present challenging vascular-access conditions, increasing the importance of devices that enable clinicians to establish access quickly during critical care situations.
Advancements in emergency medical device technology improving intraosseous access safety and efficiency
Advancements in emergency medical device technology are strengthening the intraosseous infusion devices market by improving the safety, usability, and efficiency of intraosseous access. Better device designs can support more controlled insertion and access procedures, helping emergency personnel establish vascular access with greater consistency when immediate treatment is required.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising emergency care cases and trauma incidence increasing demand for rapid vascular access solutions | 2.00% | Moderate | North America | High | Near Term |
| Growing geriatric population and cardiovascular disease burden driving emergency intervention needs | 1.80% | High | North America, Europe | High | Mid Term |
| Advancements in emergency medical device technology improving intraosseous access safety and efficiency | 1.60% | Moderate | Asia Pacific, North America | Medium | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the intraosseous infusion devices market, North America accounted for the largest share of 43.78% in 2026, reflecting strong emergency medical infrastructure, established trauma-care systems, and widespread awareness of rapid vascular access techniques. Intraosseous devices are particularly valuable when conventional intravenous access is difficult or time-sensitive, making them relevant across emergency departments, critical care settings, and prehospital treatment environments. Well-developed emergency response networks, standardized clinical protocols, and ongoing investments in emergency preparedness support consistent utilization. Training of emergency medical personnel and the increasing focus on rapid intervention during critical conditions further strengthen the region’s established adoption base.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, supported by expanding emergency healthcare capacity, improvements in ambulance and trauma-care systems, and increasing investment in critical care infrastructure. Healthcare providers are placing greater emphasis on rapid stabilization and reliable access to medications and fluids during emergencies, encouraging interest in intraosseous infusion as an alternative when intravenous access cannot be quickly established. Growing healthcare modernization, expansion of emergency departments, and increasing clinical training are creating favorable conditions for adoption. Greater awareness of advanced emergency medical technologies is also helping broaden the potential use of these devices across hospitals and prehospital care environments.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Response ReadinessGermany emphasizes dependable intraosseous access devices for emergency departments and intensive care settings. Hospitals in Germany focus on clinically validated products that support standardized emergency response protocols and practitioner confidence.
France 🇫🇷
Hospital Emergency SupportFrance is incorporating intraosseous infusion devices into hospital emergency care and advanced life support practices. Clinical teams in France seek devices that simplify emergency procedures while maintaining consistent patient safety standards.
Italy 🇮🇹
Critical Access PreparednessItaly is reinforcing emergency medical capabilities with greater availability of intraosseous infusion technologies. Healthcare institutions in Italy focus on reliable devices that support rapid intervention during trauma, resuscitation, and critical care scenarios.
Japan 🇯🇵
Acute Care PrecisionJapan is strengthening emergency preparedness through advanced infusion technologies for critical care environments. Medical facilities in Japan increasingly value intraosseous devices that offer ease of use, procedural accuracy, and reliable performance.
South Korea 🇰🇷
Trauma Care EnhancementSouth Korea is expanding the use of intraosseous infusion devices in emergency and trauma care services. Healthcare providers in South Korea prioritize portable systems that enable rapid vascular access while supporting efficient clinical workflows.
United States 🇺🇸
Emergency Care IntegrationThe U.S. continues expanding intraosseous infusion device adoption across emergency medicine, military healthcare, and prehospital care. Healthcare providers in the U.S. prioritize rapid vascular access solutions that improve treatment efficiency during critical interventions.
Segment Leadership and Growth Trends
Intraosseous Infusion Devices Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Manual IO Needles (Largest Segment) vs Battery Powered Driver (Fastest-Growing Segment)
Manual IO needles accounted for the largest share of the intraosseous infusion devices market at 52.36% in 2026, reflecting their established role in emergency vascular access when conventional intravenous access is difficult or delayed. Their relatively simple design, portability, and readiness for use make them valuable in emergency departments, critical care, and prehospital settings. The need for rapid access to circulation during urgent medical situations, combined with familiarity among healthcare professionals, supports the continued prominence of manual IO needles.
Battery powered drivers are gaining traction as healthcare providers seek faster and more controlled intraosseous access during time-sensitive procedures. Powered insertion mechanisms can reduce the physical effort associated with manual placement and provide greater consistency when accessing difficult anatomical sites. Increasing emphasis on rapid emergency intervention, improved procedural ergonomics, and technological advancement in emergency medical equipment is supporting adoption of battery powered drivers across acute-care and emergency response environments.
End-use Segment Analysis: Hospitals and Clinics (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
The hospitals and clinics segment represented the largest share of the intraosseous infusion devices market at 57.65% in 2026, owing to the concentration of emergency, trauma, critical-care, and acute medical procedures in these settings. Hospitals require reliable vascular-access alternatives when intravenous access is challenging, particularly during severe emergencies where treatment cannot be delayed. Established emergency protocols, trained clinical personnel, and broad availability of critical-care services continue to sustain demand for intraosseous infusion devices in hospitals and clinics.
Ambulatory surgical centers are emerging as the faster-growing end-use segment as healthcare delivery increasingly shifts toward efficient, procedure-focused outpatient environments. Although their clinical scope differs from that of hospitals, these centers benefit from technologies that support rapid intervention and streamlined patient management when urgent vascular access is required. Growing adoption of outpatient procedures, emphasis on shorter care pathways, and continued improvements in ambulatory surgical capabilities are creating additional opportunities for intraosseous infusion devices in these settings.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Manual IO Needles, Battery Powered Driver, Impact Driven Devices | Manual IO Needles | Battery Powered Driver |
| End-use | Hospitals and Clinics, Ambulatory Surgical Centers, Others | Hospitals and Clinics | Ambulatory Surgical Centers |
Competitive Landscape and Market Positioning
Major players in the intraosseous infusion devices market:
1. Teleflex Incorporated (United States)
2. Becton Dickinson and Company (United States)
3. Cook Medical LLC (United States)
4. SAM Medical Products (United States)
5. Cardinal Health Inc. (United States)
6. Argon Medical Devices Inc. (United States)
7. Aero Healthcare Pty Ltd. (Australia)
8. BIOPSYBELL S.R.L. (Italy)
9. Pyng Medical Corporation (Canada)
10. PerSys Medical Inc. (United States)
The intraosseous infusion devices market is evolving with increasing focus on rapid emergency access solutions. Innovation emphasizes improving insertion speed and reliability under critical conditions. The intraosseous infusion devices market is also shaped by demand for advanced trauma care equipment. Enhanced device design is improving clinical responsiveness in emergency settings.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Teleflex Incorporated (United States) | |||||||
| Becton Dickinson and Company (United States) | |||||||
| Cook Medical LLC (United States) | |||||||
| SAM Medical Products (United States) | |||||||
| Cardinal Health Inc. (United States) | |||||||
| Argon Medical Devices Inc. (United States) | |||||||
| Aero Healthcare Pty Ltd. (Australia) | |||||||
| BIOPSYBELL S.R.L. (Italy) | |||||||
| Pyng Medical Corporation (Canada) | |||||||
| PerSys Medical Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Teleflex Incorporated | Jun-23 | Teleflex received U.S. FDA 510(k) clearance in June 2023 for its Arrow EZ-IO intraosseous needle with MR conditional labeling. The device is a core component of the EZ-IO vascular access system and is designed to enable rapid, precise intraosseous insertion in emergency care settings. |
| PAVmed | Mar-22 | PAVmed reported successful first-in-human implantations of its PortIO Intraosseous Infusion System in March 2022. The early clinical study involved multiple patients under IRB approval, evaluating long-term intraosseous access performance in a controlled clinical setting. |
| Safeguard Medical | Jan-22 | Safeguard Medical launched the NIO+ Adult intraosseous device in January 2022. The ultra-compact system is engineered for durability and rapid vascular access in high-stress emergency environments, strengthening pre-hospital and trauma care capabilities. |
| SAM Medical | Mar-20 | SAM Medical launched the SAM IO Intraosseous Access System in March 2020. The manually operated device supports rapid vascular access for hospital, pre-hospital, military, and civilian emergency care applications, expanding options for critical fluid and drug delivery. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Intraosseous Infusion Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Patient Age Group | Pediatric, Adult, Geriatric |
| Clinical Indication | Trauma and Hemorrhage, Cardiac Arrest, Shock and Severe Dehydration, Other Critical Emergencies |
| Route to Market | Direct Sales, Distributor Sales, Group Purchasing Organizations |
Intraosseous Infusion Devices Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Emergency Care Workflow Integration |
|
| Trauma Care Infrastructure Opportunity Mapping |
|
| Clinical Training and Adoption Strategy |
|
Need a different cut of the data?
Request Custom ResearchHow big is the intraosseous infusion devices market?
What is the anticipated CAGR of the intraosseous infusion devices industry?
How are rising emergency and trauma cases influencing adoption of intraosseous infusion devices?
What role are technological improvements playing in the wider clinical adoption of intraosseous access systems?
Why do Manual IO Needles hold the largest share of the intraosseous infusion devices market?
Why are Ambulatory Surgical Centers the fastest-growing end-use segment in the intraosseous infusion devices market?
Why is North America the largest market for intraosseous infusion devices?
What factors are accelerating market growth in Asia Pacific?
Who are the major participants shaping the intraosseous infusion devices landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization